Phe*-Ala-based pentapeptide mimetics are BACE inhibitors: P2 and P3 SAR

Jason Lamar1, Jingdan Hu, Ana Belen Bueno

  • 1Lilly Research Laboratories, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN 46285, USA.